Related Experiment Video
Updated: Jul 7, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Oral anticoagulation after myocardial infarction
1Department of Internal Medicine, Ullevål University Hospital, Oslo, Norway. mehu@uus.no
Herz
|February 15, 2008
Summary
Oral anticoagulants (OAC) are superior to aspirin for preventing thromboembolic events post-myocardial infarction (MI). Combined OAC and low-dose aspirin therapy offers benefits with adequate anticoagulation intensity and strict INR control.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Secondary prevention after myocardial infarction (MI) is crucial.
- Oral anticoagulants (OAC) are established therapies.
- The role of OAC in combination with aspirin requires further clarification.
Purpose of the Study:
- To review the efficacy and safety of OAC in secondary prevention post-MI.
- To evaluate the combination therapy of OAC and low-dose aspirin.
Main Methods:
- Review of large randomized clinical trials.
- Analysis of recently published trials and meta-analyses.
- Focus on thromboembolic events and bleeding complications.
Main Results:
- OAC demonstrated superiority over aspirin in reducing thromboembolic events post-MI.
- Combined OAC and low-dose aspirin therapy is beneficial with adequate anticoagulation (INR 2.0-2.5).
- Serious and fatal bleeding risks with combined therapy are comparable to OAC alone.
Conclusions:
- OAC are effective for secondary prevention post-MI.
- Combined OAC and low-dose aspirin therapy is a viable option with careful management.
- Patient compliance and strict International Normalized Ratio (INR) control are essential for optimal outcomes.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...